Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
GSDME-mediated target cell pyroptosis by CAR T cells activates macrophages to release proinflammatory cytokines for CRS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment for CRS and associated neurotoxicity primarily targets IL-6, likely arising from monocytes or activated endothelium [1, 6, 11–17].”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [14]
In the citing paper
“Tumor lysis most likely also contributes to the cytokine storm through the induction of pyroptosis in target cells.55”
From Cytokine storm (2020) · cites this paper as [55]
Citations
Cites
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Self-citationChimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Wang, Y., Gao, W., Shi, X., Ding, J., Liu, W., He, H., Wang, K., & Shao, F. (2017) · Nature · doi:10.1038/nature22393 · Cited by 3,199
U.S. Department of Health and Human Services
(2006) · Encyclopedia of Sexual Behavior and the Law · doi:10.4135/9781452240107.n226 · Cited by 3,170
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Shi, J., Gao, W., & Shao, F. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.004 · Cited by 3,088
Lee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898
Pore-forming activity and structural autoinhibition of the gasdermin family
Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Sun, H., Wang, D.-C., & Shao, F. (2016) · Nature · doi:10.1038/nature18590 · Cited by 2,771
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Park, J. H., Rivière, I., Gonen, M., Wang, X., Sénéchal, B., Curran, K. J., Sauter, C., Wang, Y., Santomasso, B., Mead, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709919 · Cited by 2,688
Cited by
Items 101–200 of 567
The dilemmas and possible solutions for CAR-T cell therapy application in solid tumors
Wang, L., Zhang, L., Dunmall, L. C., Wang, Y. Y., Fan, Z., Cheng, Z., & Wang, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216871 · Cited by 62
Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs
Zhang, S., Liang, Y., Yao, J., Li, D., & Wang, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.833588 · Cited by 68
“It has been shown that CAR T cells release Granzyme B (GZMB), which triggers GSDME-mediated target cell pyroptosis to cause CRS (Liu et al., 2020).”
BackgroundLiu, Z., Wang, C., & Lin, C. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121498 · Cited by 60
Wu, L., Zhang, Y., Yang, Y., Lin, B., Zhu, M., Xu, J., Chen, Y., Wu, W., Chen, B., Chen, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202303908 · Cited by 59
Self-citationZheng, Z.-Y., Yang, P.-L., Li, R.-Y., Liu, L.-X., Xu, X., Liao, L., Li, X., Chu, M.-Y., Liu, P., Huang, Q., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.035 · Cited by 65
Ouyang, B., Shan, C., Shen, S., Dai, X., Chen, Q., Su, X., Cao, Y., Qin, X., He, Y., Wang, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51980-9 · Cited by 72
“Considering our previously hypothesized adjuvant role of GZMB on MG@PM-induced pyroptosis, we examined the immune micro-environment in metastatic tumor tissues of the lungs and noticed a distinct population of CD8 + T cells in MG@PM group (Supplementary Fig.39) 58,59 .”
Role of pyroptosis in cancer cells and clinical applications
Ju, X., Yang, Z., Zhang, H., & Wang, Q. (2021) · Biochimie · doi:10.1016/j.biochi.2021.03.007 · Cited by 58
Methods for monitoring cancer cell pyroptosis
Wang, S., Liu, Y., Zhang, L., & Sun, Z. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0504 · Cited by 60
Self-citationEliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
Wang, W., Zhang, L., & Sun, Z. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0049 · Cited by 60
Cell death affecting the progression of gastric cancer
Wang, H., Liu, M., Zeng, X., Zheng, Y., Wang, Y., & Zhou, Y. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01161-8 · Cited by 60
“In cancer immunotherapy, cytokine release syndrome (CRS) caused by CAR-T therapy is a serious complication that usually intensifies with increasing CAR-T efficacy.”
BackgroundInfluentialSelf-citationLiu, D., Xu, X., Dai, Y., Zhao, X., Bao, S., Ma, W., Zha, L., Liu, S., Liu, Y., Zheng, J., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001466 · Cited by 60
“25 26 27–30 We speculated that activation of the AIM2 inflammasome during the CAR-T treatment might be triggered by the dsDNA, which is released from dying tumor cells and engulfed by macrophages.”
Self-citationOptimization of CAR-T Cell-Based Therapies Using Small-Molecule-Based Safety Switches
Zheng, Y., Nandakumar, K. S., & Cheng, K. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02054 · Cited by 57
Role of Serine Proteases at the Tumor-Stroma Interface
Tagirasa, R., & Yoo, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.832418 · Cited by 62
“Activation of gasdermin B (GSDMB) by GzmA (90) or GSDME by GzmB (and indirectly by caspase-3) initiates pyroptotic cell death in tumors (91).”
BackgroundGalli, E., Sorà, F., Hohaus, S., Fresa, A., Pansini, I., Autore, F., Metafuni, E., Innocenti, I., Limongiello, M. A., Giammarco, S., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18596 · Cited by 62
Zhao, Q., Chen, D., Chen, H., Wang, Y., Shi, W. L., Lu, Y., Ren, Y.-Z., Wu, Y., Pang, Y., Deng, H. X., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000868 · Cited by 67
“…in liver damage and plays a Despite recent success in demonstrating the importance of pyroptosis in reshaping environments to trigger tumor progression and therapeutic resistance, [14,30,39,46] the direct function and regulation of this cell death during HBV-ACLF progression are still unclear.”
Gasdermins as evolutionarily conserved executors of inflammation and cell death
Chen, K. W., & Brož, P. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01474-z · Cited by 64
“However, excessive GSDME activation in tumours following chimeric antigen receptor (CAR) T cell therapy can in turn promote inflammasome assembly in macrophages and elicit a life-threatening cytokine response syndrome 82 .”
Pyroptosis and Redox Balance in Kidney Diseases
Cuevas, S., & Pelegrín, P. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8243 · Cited by 59
“…of cytokine release syndrome in patients, and knocking out Gasdermin E in mice has inhibited caspase-1 and abrogated severe cytokine release (106), establishing a strong association between cytokine activation and expression with Gasdermin E. PJVK is the most distinct Gasdermin because its…”
Deng, T., Tang, C., Zhang, G., & Wan, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03428-x · Cited by 57
Pyroptosis, inflammasome, and gasdermins in tumor immunity
Ouyang, X., Zhou, J., Lin, L., Zhang, Z., Luo, S., & Hu, D. (2023) · Innate Immunity · doi:10.1177/17534259221143216 · Cited by 58
“In addition, it showed that chimeric antigen receptor (CAR) T cells, rather than existing CD8 T cells, by virtue of their release of a large amount of perforin and granzyme B, activated the caspase 3–GSDME pathway in tumors, leading to pyroptosis.(88) Importantly, the tumor suppressive effect of GSDME is abrogated in…”
BackgroundSelf-citationCTLA-4 blockade induces tumor pyroptosis via CD8+ T cells in head and neck squamous cell carcinoma
Wang, S., Wu, Z., Zhu, S., Wan, S., Zhang, M.-J., Zhang, B., Yang, Q., Xiao, Y., Li, H., Mao, L., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.023 · Cited by 58
Self-citationSupramolecular Biomaterials for Cancer Immunotherapy
Liang, H., Lu, Q., Yang, J., & Yu, G. (2023) · Research · doi:10.34133/research.0211 · Cited by 53
The crosstalk between immune cells and tumor pyroptosis: advancing cancer immunotherapy strategies
Hu, M., Deng, F., Song, X., Zhao, H., & Yan, F. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03115-7 · Cited by 64
“Furthermore, studies suggest that TAMs release pro-inflammatory cytokines to trigger CRS and participate in the granzyme pathway, which is relevant for CAR-T cell therapy [63] (Fig.”
BackgroundInfluentialPANoptosis in cancer, the triangle of cell death
Cai, H., Lv, M., & Wang, T. (2023) · Cancer Medicine · doi:10.1002/cam4.6803 · Cited by 60
“149 Similarly, CRS can be triggered by PANoptosis, and targeting specific pathways in PANoptosis to attenuate or block CRS would be a significant advancement for CAR-T therapy.”
BackgroundWang, X., Guo, X., Ren, H., Song, X., Chen, L., Yu, L., Ren, J., & Chen, Y. (2024) · Advanced Materials · doi:10.1002/adma.202415814 · Cited by 65
Transcription factor Sp1 transcriptionally enhances GSDME expression for pyroptosis
Pan, J., Li, Y., Gao, W., Jiang, Q., Geng, L., Ding, J. J., Li, S., & Li, J. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06455-6 · Cited by 58
“Tumor cells also undergo caspase 3-GSDME axis-mediated pyroptosis while attacked by NK cells, effector T cells, or CAR-T cells [11, 12].”
InfluentialPyroptosis, a New Breakthrough in Cancer Treatment
Wu, D., Wei, C., Li, Y., Yang, X., & Zhou, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698811 · Cited by 57
Pyroptosis, a target for cancer treatment?
Huang, Y., Wang, J., Huang, J., Tang, L., Xu, Y., Sun, H., Tang, J., & Wang, G. (2022) · APOPTOSIS · doi:10.1007/s10495-021-01703-y · Cited by 53
Delivery of Plasmid DNA by Ionizable Lipid Nanoparticles to Induce CAR Expression in T Cells
Prazeres, P. H. D. M., Ferreira, H. A. S., Costa, P. A. C., da Silva, W., Alves, M. T. R., Padilla, M. S., Thatte, A. S., Santos, A. K., Lobo, A. O., Sabino, A. D. P., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s424723 · Cited by 54
“34,39,40 Although durable remissions are induced by this therapy, long-term adverse effects such as B-cell aplasia, 14 cytokine release syndrome, 41,42 and neurotoxicity 43 are commonly observed.”
BackgroundRecent advances in caspase-3, breast cancer, and traditional Chinese medicine: a review
Dou, H., Yu, P. Y., Liu, Y. Q., Zhu, Y., Li, F. C., Wang, Y. Y., Chen, X. Y., & Xiao, M. (2023) · Journal of Chemotherapy · doi:10.1080/1120009x.2023.2278014 · Cited by 59
“…process was explicitly caspase-1-dependent and mediated the release of IL-1 b , causing an inflammatory response, which is different from apoptosis leukemia cells by tumor-associated macrophages and improved the number and function of tumor-infiltrating natural killer cells and CD8 þ T cells [100].”
Self-citationPyroptosis and Its Role in SARS-CoV-2 Infection
Bittner, Z., Schrader, M., George, S. E., & Amann, R. (2022) · Cells · doi:10.3390/cells11101717 · Cited by 49
“The pyroptosis of the target cells leads to Caspase 1 triggered macrophage pyroptosis which, in turn, leads to cytokine release from myeloid cells and to cytokine release syndrome [59].”
BackgroundBIX‐01294 enhanced chemotherapy effect in gastric cancer by inducing GSDME‐mediated pyroptosis
Deng, B., Jiao, B., Liu, Y., Li, Y., & Wang, G. (2020) · Cell Biology International · doi:10.1002/cbin.11395 · Cited by 50
“And we found that SGC‐7901 also expresses a high level of GSDME, which is consistent with a recent study (Liu et al., 2020).”
ResultSelf-citationNew insights into the evolutionary dynamic and lineage divergence of gasdermin E in metazoa
Yuan, Z., Jiang, S., Qin, K., & Sun, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.952015 · Cited by 46
“During pyroptosis, GSDM is cleaved by a protease, and the cleavage releases the NT fragment that induces cell death by forming pores on the plasma membrane (Ding et al., 2016; Evavold et al., 2018; Liu et al., 2020).”
BackgroundSchisandrin B induces HepG2 cells pyroptosis by activating NK cells mediated anti-tumor immunity
Song, A., Ding, T., Wei, N., Jie-ren, Y., Ma, M., Zheng, S., & Jin, H. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116574 · Cited by 49
Molecular mechanisms of pyroptosis and its role in anti-tumor immunity
Huang, H., Weng, Y., Tian, W., Lin, X., Chen, J., & Luo, L. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.86855 · Cited by 52
“The expression of GSDME increases the phagocytosis of TAMs, enhances the function of tumor-infiltrating natural-killer, and then inhibits tumor growth[50, 72].”
BackgroundInfluentialSynthetic protein circuits for programmable control of mammalian cell death
Xia, S., Lu, A. C., Tobin, V. R., Luo, K., Moeller, L., Shon, D. J., Du, R., Linton, J. M., Sui, M. Y., Horns, F., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.031 · Cited by 55
Pyroptosis in cancer therapy: a double-edged sword for immune activation and tumor progression
Alishvandi, A., Aram, C., Shahrivar, F. F., Kesharwani, P., & Sahebkar, A. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02506-4 · Cited by 61
“…active form of caspase-1 cleaves GSDMD in macrophages, inducing the secretion of cytokines such as IL-1 and IL-6, and stimulating CRS. Notewor-thy, the key factor for CAR-T cells to induce pyroptosis in target cells is the amount of perforin/granzyme B used, not the presence of CD8 + T cells [135].”
InfluentialQiu, S., Hu, Y., & Dong, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108270 · Cited by 48
Self-citationSARS-CoV-2: Is the liver merely a bystander to severe disease?
Bangash, M. N., Patel, J. M., Parekh, D., Murphy, N., Brown, R. M., Elsharkawy, A. M., Mehta, G., Armstrong, M. J., & Neil, D. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.035 · Cited by 45
Bright future or blind alley? CAR-T cell therapy for solid tumors
Zhang, K., Chen, H., Li, F., Sheng, H., Chen, F., & Li, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1045024 · Cited by 56
“found that CAR T cells rapidly released granzyme B in tumor cells to activate caspase 3, causing the subsequent gasdermin E (GSDME) cleavage and the release of cytokines, thus inducing CRS (99).”
BackgroundLutetium texaphyrin: A photocatalyst that triggers pyroptosis via biomolecular photoredox catalysis
Xu, Y., Chau, C. V., Lee, J., Sedgwick, A. C., Yu, L., Li, M., Peng, X., Kim, J. S., & Sessler, J. L. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2314620121 · Cited by 52
“…the expectation that GSDME pore formation on the cell membrane could trigger the release of proinflammatory cytokines, such as IL - 1 β and IL - 18 (54, 55), we tested whether excreted IL - 1 β was present in the cell culture supernatant of MDA - MB - 231 cells under various test conditions.”
MethodPyroptosis: A Novel Intervention Target in the Progression of Osteoarthritis
Chang, X., Kang, Y., Yang, Y., Chen, Y., Shen, Y., Jiang, C., & Shen, Y. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s368501 · Cited by 47
“Moreover, granzyme A and granzyme B directly and indirectly induce GSDMB and GSDME cleavage, respectively.(34,35) These findings suggest that there is heterogeneity in”
BackgroundMesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression
Sirpilla, O. L., Sakemura, R. L., Hefazi, M., Huynh, T., Can, İ., Girsch, J. H., Tapper, E. E., Cox, M. J., Schick, K. J., Manriquez-Roman, C., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01195-6 · Cited by 47
Improving safety of cancer immunotherapy via delivery technology
Hu, D., Zhang, W., Tang, J., Zhou, Z., Liu, X., & Shen, Y. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120407 · Cited by 47
GSDME: A Potential Ally in Cancer Detection and Treatment
Ibrahim, J., Schutter, E. D., & de Beeck, K. O. (2021) · Trends in cancer · doi:10.1016/j.trecan.2020.12.002 · Cited by 44
A Novel Classification Model for Lower-Grade Glioma Patients Based on Pyroptosis-Related Genes
Shen, Y., Chi, H., Xu, K., Li, Y., Yin, X., Chen, S., Yang, Q., He, M., Zhu, G., & Li, X. (2022) · Brain Sciences · doi:10.3390/brainsci12060700 · Cited by 49
“Pyroptosis is a relatively new form of programmed cell death associated with various therapies, including radiation [4], chemotherapy [5], targeted therapy [6], and immunotherapy [7].”
BackgroundPyroptosis: shedding light on the mechanisms and links with cancers
You, H., Wang, L., Meng, H., Huang, C., Fang, G.-Y., & Li, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1290885 · Cited by 43
“As a result, pyroptosis-freed in fl ammatory factors will further activate caspase-1/GSDMD and the MAPK-NF-k B pathway, causing cytokine release syndrome (CRS) (54).”
BackgroundBioorthogonally Activatable Base Editing for On-Demand Pyroptosis
Ngai, W. S. C., Yang, S., Zeng, X., Liu, Y., Lin, F., Wang, X., Zhang, H., Fan, X., & Chen, P. R. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c12924 · Cited by 42
Self-citationCancer-associated pyroptosis: A new license to kill tumor
Kong, Q., & Zhang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1082165 · Cited by 48
“Secondary activation of GSDMD pyroptosis by CAP alarmins in tumor-associated macrophages lies at the root of CAR-T cell-triggered cytokine release syndrome, a severe adverse effect of CAR-T immunotherapy (53).”
BackgroundInfluentialSelf-citationWhat role does pyroptosis play in cancer?
Huang, C. L., Li, J., & Zhang, C. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101587 · Cited by 44
“PCD programmed cell death GSDMD gasdermin D GSDME gasdermin E TAK1 transforming growth factor-b activated kinase 1 IAP inhibitor of apoptosis GERD Gastroesophageal reflux disease ESCC esophageal squamous cell carcinoma CDK2 cycle protein-dependent kinase HCC Hepatocellular carcinoma CRC colorectal cancer LC lung cance…”
BackgroundGasdermin D-mediated pyroptosis is regulated by AMPK-mediated phosphorylation in tumor cells
Chu, X., Xiao, X., Wang, G., Uosef, A., Lou, X., Arnold, P. R., Wang, Y., Kong, G., Wen, M., Minze, L. J., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06013-6 · Cited by 45
“Gasdermin A- or gasdermin E-mediated pyroptosis can initiate an efficient antitumor immunity in mouse model [2, 3, 36, 40], making gasdermin a promising tool to improve the survival of cancer patients.”
BackgroundPyroptosis and inflammasomes in cancer and inflammation
Wang, J., Hua, S., Bao, H., Yuan, J., Zhao, Y., & Chen, S. (2023) · MedComm · doi:10.1002/mco2.374 · Cited by 47
Zhou, Y., Wang, D., Zhou, L., Zhou, N., Wang, Z., Chen, J., Pang, R., Fu, H., Huang, Q., Dong, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45750-w · Cited by 48
“This pattern raises the obvious concern that the scaling of each image was tailored either to highlight the existence of pores (by shrinking the scaling, thereby emphasizing variation) or to make them less apparent (by expanding the scaling, thereby smoothing things out).”
Self-citationBiological mechanisms and therapeutic relevance of the gasdermin family
Xia, S. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100890 · Cited by 46
“In another case, researchers emphasized the ability of chimeric antigen receptor (CAR) T cells, rather than existing CD8+ cells, to induce target cell pyroptosis also through perforindependent direct activation of GSDME by granzyme B (Liu et al., 2020).”
BackgroundComplete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies
Yang, C., Nguyen, J., & Yen, Y. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00982-8 · Cited by 45
“In addition to caspase 3 activation in the target cells, granzyme A and granzyme B were found to cleave gasdermin D (GSDMD) and E (GSDME), respectively, which are hallmarks of pyroptosis [47–50].”
BackgroundResultCancer Treatment Evolution from Traditional Methods to Stem Cells and Gene Therapy
Dong, C., He, W., Li, Q., Lü, Y., Ju, D., Gu, Y., & Zhao, K. (2021) · Current Gene Therapy · doi:10.2174/1566523221666211119110755 · Cited by 45
A Comparative Review of Pyroptosis in Mammals and Fish
Song, Z., Zou, J., Wang, M., Chen, Z., & Wang, Q. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s361266 · Cited by 40
“The latter cleaves gasdermin E (GSDME), a pore-forming protein highly expressed in B leukemic and other target cells, which results in extensive pyroptosis.(34) GzmB is also reported to directly cleave GSDME and induce cell death, thereby activating the anti-tumor immune responses to inhibit tumor growth.”
BackgroundThe regulatory role and therapeutic application of pyroptosis in musculoskeletal diseases
Wang, S., Wang, H., Feng, C., Li, C., Li, Z., He, J., & Tu, C. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01282-0 · Cited by 46
“Granzyme B released by chimeric antigen receptor (CAR) T cells directly cleaves GSDME and activates caspase-3 to enhance GSDME pore formation indirectly [23].”
BackgroundFattinger, S. A., Maurer, L., Geiser, P., Bernard, E. M., Enz, U., Ganguillet, S., Gül, E., Kroon, S., Demarco, B., Mack, V., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315503120 · Cited by 38
Chen, L., Liu, X., Yu, J., Shi, L., Wei, W., Zhu, Y., Feng, M., Tang, T., Li, D., Yang, T., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.01.042 · Cited by 40
“Moreover, granzymes A and B, which are secreted by cytotoxic lymphocytes, can cleave GSDMB and GSDME, respectively, to induce pyroptosis [16,20].”
Chen, P., Tang, Y., He, W., Yang, R., Lan, Z., Chen, R., & Zhang, P. (2022) · Mediators of Inflammation · doi:10.1155/2022/7137900 · Cited by 44
Liao, Y., Wang, X., Huang, L., Qian, H., & Liu, W. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1122104 · Cited by 40
“Note that the cleavage of GSDME produces an N-terminal fragment of GADME, which encourages the creation of membrane pores, hence causing pyroptosis, following caspase-3 activation by granzyme B (GZMB) generated from natural killer cells (Liu et al., 2020).”
BackgroundLi, X., Xiao, G.-Y., Guo, T., Song, Y., & Li, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.986565 · Cited by 44
Napodano, C., Carnazzo, V., Basile, V., Pocino, K., Stefanile, A., Gallucci, S., Natali, P., Basile, U., & Marino, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316556 · Cited by 41
“Indeed, in addition to genetic predisposition, the tumor burden is an important factor associated with the severity of the cytokine storm during CAR T-cell therapy [108].”
BackgroundKuang, S., Sheng, W., Meng, J., Liu, W., Xiao, Y., Tang, H., Fu, X., Kuang, M., He, Q., & Gao, S. (2024) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.06.014 · Cited by 45
“It has been demonstrated that granzyme B secreted by chimeric antigen receptor T cells is able to activate caspase-3, and the activated caspase-3 subsequently forms GSDME-N by cleaving GSDME and forming stomata in the plasma membrane leading to pyroptosis [58,59].”
BackgroundXia, P., Xing, X., Yang, C., Liao, X., Liu, F., Huang, H.-H., Zhang, C., Song, J., Jiao, Y., Shi, M., et al. (2022) · Military Medical Research · doi:10.1186/s40779-022-00384-1 · Cited by 46
“GSDMD or gasdermin-E (GSDME) in human B leukemic cells can be activated by chimeric antigen receptor T cell-released granzyme B [35] and activated GSDMD is required for an optimal cytotoxic T lymphocyte response to lung cancer cells [36].”
BackgroundChen, H., Ding, B., Tan, J., Meng, Q., Li, J., Zhang, W., Zheng, P., Liu, B., Ma, P., & Lin, J. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202501530 · Cited by 38
Zhang, Q., Wang, J., Huang, F., Yao, Y., & Xu, L. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.10.025 · Cited by 40
Serrano‐López, J., & Martín-Antonio, B. (2021) · Cells · doi:10.3390/cells10102562 · Cited by 43
“Of interest, in CAR-T cellimmunotherapy, NLRP3 activates pyroptosis with release of DAMPs, IL1β and IL6 [53].”
BackgroundInfluentialHong, F., Shi, M., Cao, J., Wang, Y., Gong, Y., Gao, H., Li, Z., Zheng, J., Zeng, L., He, A., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17029 · Cited by 37
Tang, Y., Xu, Q., Luo, H., Yan, X., Wang, G., Hu, L., Jin, J., Witte, D. P., Marsh, R. A., Huang, L., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.06.017 · Cited by 40
Epigenetic regulation of pyroptosis in cancer: Molecular pathogenesis and targeting strategies
Zhang, R., Jing, Z.-Q., Zhang, L., & Sun, Z. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216413 · Cited by 34
Zhao, Y., Zhang, X., Zhang, M., Guo, R., Zhang, Y., Pu, Y., Zhu, H., Liu, P., Zhang, Y., He, X., et al. (2024) · Annals of Hematology · doi:10.1007/s00277-024-05617-y · Cited by 36
Self-citationFerroptosis and Pyroptosis in Epilepsy
Feng, F., Luo, R., Mu, D., & Cai, Q. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04018-6 · Cited by 41
“In 2020, Liu et al. [59] reported that chimeric antigen receptor T cells quickly activate caspase-3 in target cells by releasing GZMB, and then, caspase-3 cleaves GSDME that is abundantly expressed in target cells, thus leading to widespread pyroptosis.”
Regulated cell death in cancer: Mechanisms, crosstalk, and opportunities for therapy
Meng, Y., Chen, Q., Zhou, Z., & Li, M. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218077 · Cited by 47
Pyroptosis: A road to next-generation cancer immunotherapy
Fang, Y., Tang, Y., & Huang, B. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101782 · Cited by 36
Self-citationViral gene delivery vectors: the next generation medicines for immune-related diseases
De Haan, P., Van Diemen, F. R., & Toscano, M. G. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1757989 · Cited by 34
“Although highly successful, a major disadvantage of using LV vectors for T cell therapies is that the CAR-positive T cells remain permanently in the bloodstream of treated patients, continuously removing body cells that express tumor antigens at their surface.(51) LV vector-based T cell therapies targeting self-protei…”
BackgroundThe dance of macrophage death: the interplay between the inevitable and the microenvironment
Makuch, M., Stepanechko, M., & Bzowska, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1330461 · Cited by 38
Recent advances in targeted drug delivery for the treatment of glioblastoma
Mao, M., Wu, Y., & He, Q. Z. (2024) · Nanoscale · doi:10.1039/d4nr01056f · Cited by 37
Induction of pyroptotic cell death as a potential tool for cancer treatment
Faria, S. S., Fernando, A. J., de Lima, V. C. C., Rossi, A. G., de Carvalho, J. M. A., & Magalhães, K. G. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00316-9 · Cited by 36
“In this sense, GZMB cleaves GSDME in the same region as caspase-3, while GSDMB can be cleaved by GZMA [27, 28].”
BackgroundApoptosis‐Sensitizing Tumor Nanomedicine by Regulating Pyroptosis‐Associated Inflammatory Cell Death
Du, F., Zhao, H., Song, Y., Feng, Z., Liu, K., Wang, Z., Guo, R., Li, Q., Chen, Q., & Zhou, L. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202406150 · Cited by 34
Self-citationPyroptosis: A spoiler of peaceful coexistence between cells in degenerative bone and joint diseases
Li, Z., Cheng, W., Gao, K., Liang, S., Ke, L., Wang, M., Fan, J., Li, D., Zhang, P., Xu, Z., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.06.010 · Cited by 41
“Moreover, granzymes A and B have been found to induce extensive pyroptosis by cleaving GSDMB and GSDME, respectively [38,39].”
Mechanisms of Gasdermin Recognition by Proteases
Liu, Z., Busscher, B. M., Storl-Desmond, M., & Xiao, T. S. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167274 · Cited by 33
Resisting T cell attack: tumor-cell-intrinsic defense and reparation mechanisms
McKenzie, B., & Valitutti, S. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.12.003 · Cited by 34
Miao, Y., Quan, W., Dong, X., Gan, J., Ji, C.-F., Wang, J., & Zhang, F. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01421-1 · Cited by 34
Cytokine signaling in chimeric antigen receptor T-cell therapy
Kagoya, Y. (2023) · International Immunology · doi:10.1093/intimm/dxad033 · Cited by 34
“(86) demonstrated that granzyme B secreted from CAR-T cells activates caspase 3 within tumor cells, which then cleaves gasdermin E and causes pyroptosis—inflammatory programmed cell death that triggers the activation of adjacent macrophages through secretion of damage-associated molecular patterns…”
BackgroundNanomedicine-induced programmed cell death enhances tumor immunotherapy
Lu, J., Tai, Z., Wu, J., Li, L., Zhang, T., Liu, J., Zhu, Q., & Chen, Z. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.09.018 · Cited by 34
Self-citationGasdermin D and Beyond – Gasdermin-mediated Pyroptosis in Bacterial Infections
Booty, L. M., & Bryant, C. E. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167409 · Cited by 33
A pan-cancer analysis of molecular characteristics and oncogenic role of gasdermins
Mu, M., Yu, Q., Zhang, Q., Guo, J., Wang, X., Sun, X., & Yu, J. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02483-4 · Cited by 33
“Later, GSDME and GSDMB have been uncovered to play a critical role in inducing pyroptosis [11, 27], further reinforcing the idea that GSDM genes have the pore-forming and cell lysis ability.”
Ma, B., Liu, X., Zhang, Z., Ma, C., Chand, R., Patwardhan, S., Wang, C., Thamphiwatana, S., Chen, P., & Chen, W. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115247 · Cited by 31
Self-citationConrad, M., Strasser, A., Jost, P. J., Yuan, J., Shao, F., Vandenabeele, P., & Wahida, A. (2026) · Cell · doi:10.1016/j.cell.2026.03.024 · Cited by 45
Inflammatory cell death induced by cytotoxic lymphocytes: a dangerous but necessary liaison
de Miguel, D., Ramírez-Labrada, A., Uranga-Murillo, I., Hidalgo, S., Santiago, L., Gálvez, E. M., Arias, M. A., & Pardo, J. (2021) · FEBS Journal · doi:10.1111/febs.16093 · Cited by 36
“18 However, it is also true that too much pyroptosis can be detrimental, as exemplified by 19 the GSDME mediated CRS occurring during CART cell therapy [133].”
BackgroundTranscriptional and Epigenetic Regulation of Gasdermins
Bourdonnay, E., & Henry, T. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167253 · Cited by 33
Demarco, B., Danielli, S., Fischer, F. A., & Bezbradica, J. S. (2022) · Cells · doi:10.3390/cells11081307 · Cited by 33
Research Progress on Nanoparticles-Based CRISPR/Cas9 System for Targeted Therapy of Tumors
Nie, D., Guo, T., Yue, M., Li, W., Zong, X., Zhu, Y., Huang, J., & Lin, M. (2022) · Biomolecules · doi:10.3390/biom12091239 · Cited by 36
Pore forming–mediated intracellular protein delivery for enhanced cancer immunotherapy
Zhou, Z., Yang, R., Dong, J., Di, Y., Yang, Y., Huang, Y., Yang, X., Liu, W., Wang, J., Liu, P., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq4659 · Cited by 32
Pyroptosis in myocardial ischemia/reperfusion and its therapeutic implications
Liu, Y., Li, X., Sun, T., Li, T., & Li, Q. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176464 · Cited by 31
Self-citationWang, J., Gao, Y.-X., Ye, Y., Zheng, Q.-L., Luo, H.-Y., Wang, S., Zhang, T., Jin, Q., Zheng, C., Li, P., et al. (2024) · Theranostics · doi:10.7150/thno.93124 · Cited by 35
“…et al. demonstrated that pyroptosis of tumor cells can trigger cytokine release syndrome during chimeric antigen receptor (CAR) T-cell therapy and suggested that modifications to the natural CAR are necessary to decrease the likelihood of cytokine release syndrome resulting from pyroptosis [18].”
BackgroundSelf-citationThe “cytokine storm” in infection and sepsis: win the battle but lose the war
Fan, J., Li, Q.-Y., Feng, X.-F., Huang, S., Wang, R., Liao, F.-Y., Liu, D., Liu, W.-Y., Sun, J.-H., Zhang, H.-C., et al. (2026) · Military Medical Research · doi:10.1186/s40779-025-00678-0 · Cited by 51
Self-citationChemical Modulation of Gasdermin-Mediated Pyroptosis and Therapeutic Potential
Ryder, C. B., Kondolf, H. C., O'Keefe, M. E., Zhou, B., & Abbott, D. W. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167183 · Cited by 31
Pyroptosis: A Developing Foreland of Ovarian Cancer Treatment
Liu, T., Hou, M., Li, M., Qiu, C., Cheng, L. Z., Zhu, T., Qu, J., & Li, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.828303 · Cited by 32
Metadata
- Authors
- Liu, Y., Fang, Y., Chen, X., Wang, Z., Liang, X., Zhang, T., Liu, M., Zhou, N., Lv, J., Tang, K., Xie, J., Gao, Y., Cheng, F., Zhou, Y., Zhang, Z., Hu, Y., Zhang, X., Gao, Q., Zhang, Y., & Huang, B.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Huazhong University of Science and Technology (CN)
- Wuhan Union Hospital (CN)
- Peking University People's Hospital (CN)
- Zhengzhou University (CN)
- Corresponding author
- Liu, Yuying
- Fang, Yiliang
- Chen, Xinfeng
- Huang, Bo
- ORCID
- Venue
- Science Immunology
- Published
- 2020-01-03
- Volume
- 5
- Issue
- 43
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W2999534343
- Cited by
- 566
- References
- 45
- Citations by year
- 2026: 63 · 2025: 87 · 2024: 100 · 2023: 127 · 2022: 96 · 2021: 70 · 2020: 22
- FWCI
- 28.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81788101, 81661128007, 81530080, 81773062)
- Topics
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- gasdermin E, pyroptosis, chimeric antigen receptor T cells, cytokine release syndrome, macrophage activation, inflammatory cytokines, target cell death, adoptive T cell therapy
- MeSH terms
- Pyroptosis, Cytokine Release Syndrome, Gasdermins, Animals, Female, Humans, Macrophages, T-Lymphocytes, Leukemia, B-Cell, Immunotherapy, Adoptive, Phosphate-Binding Proteins, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Mice, Granzymes, Perforin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.